Focus Equities

Teva Launches Branded and Generic Therapies for Asthma

images (8)

Teva Pharmaceutical Industries said Thursday that it has launched AirDuo RespiClick inhalation powder and its authorized generic for the treatment of asthma.

The company said it is launching both products at the same time to offer a more affordable treatment option in the U.S., and that it expects sales of the authorized generic to represent most of the sales of the two products.
ADRs were marginally higher in recent morning trade.